Seelig SA - Search Results

1

The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine.

Sokolova IA, Halling KC, Jenkins RB, Burkhardt HM, Meyer RG, Seelig SA, King W. Sokolova IA, et al. Among authors: seelig sa. J Mol Diagn. 2000 Aug;2(3):116-23. doi: 10.1016/S1525-1578(10)60625-3. J Mol Diagn. 2000. PMID: 11229514 Free PMC article. Clinical Trial.

2

A fluorescence in situ hybridization-based assay for improved detection of lung cancer cells in bronchial washing specimens.

Sokolova IA, Bubendorf L, O'Hare A, Legator MS, Jacobson KK, Grilli B S B, Dalquen P, Halling KC, Tamm M, Seelig SA, Morrison LE. Sokolova IA, et al. Among authors: seelig sa. Cancer. 2002 Oct 25;96(5):306-15. doi: 10.1002/cncr.10720. Cancer. 2002. PMID: 12378599 Free article.

3

A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma.

Halling KC, King W, Sokolova IA, Meyer RG, Burkhardt HM, Halling AC, Cheville JC, Sebo TJ, Ramakumar S, Stewart CS, Pankratz S, O'Kane DJ, Seelig SA, Lieber MM, Jenkins RB. Halling KC, et al. Among authors: seelig sa. J Urol. 2000 Nov;164(5):1768-75. J Urol. 2000. PMID: 11025767

4

A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine.

Halling KC, King W, Sokolova IA, Karnes RJ, Meyer RG, Powell EL, Sebo TJ, Cheville JC, Clayton AC, Krajnik KL, Ebert TA, Nelson RE, Burkhardt HM, Ramakumar S, Stewart CS, Pankratz VS, Lieber MM, Blute ML, Zincke H, Seelig SA, Jenkins RB, O'Kane DJ. Halling KC, et al. Among authors: seelig sa. J Urol. 2002 May;167(5):2001-6. J Urol. 2002. PMID: 11956427

5

The role of fluorescence in situ hybridization technologies in molecular diagnostics and disease management.

King W, Proffitt J, Morrison L, Piper J, Lane D, Seelig S. King W, et al. Mol Diagn. 2000 Dec;5(4):309-19. doi: 10.1007/BF03262092. Mol Diagn. 2000. PMID: 11172495 Review.

6

Automation of fluorescence in situ hybridization pretreatment: a comparative study of different sample types.

Jacobson K, Thompson A, Browne G, Shasserre C, Seelig SA, King W. Jacobson K, et al. Among authors: seelig sa. Mol Diagn. 2000 Sep;5(3):209-20. doi: 10.1054/modi.2000.9731. Mol Diagn. 2000. PMID: 11070155

7

Chromosome-specific aneusomy in carcinoma of the breast.

Persons DL, Robinson RA, Hsu PH, Seelig SA, Borell TJ, Hartmann LC, Jenkins RB. Persons DL, et al. Among authors: seelig sa. Clin Cancer Res. 1996 May;2(5):883-8. Clin Cancer Res. 1996. PMID: 9816245

8

Gene copy mapping of the ERBB2/TOP2A region in breast cancer.

Jacobson KK, Morrison LE, Henderson BT, Blondin BA, Wilber KA, Legator MS, O'Hare A, Van Stedum SC, Proffitt JH, Seelig SA, Coon JS. Jacobson KK, et al. Among authors: seelig sa. Genes Chromosomes Cancer. 2004 May;40(1):19-31. doi: 10.1002/gcc.20019. Genes Chromosomes Cancer. 2004. PMID: 15034864

9

Fluorescence in situ hybridization: powerful molecular tool for cancer prognosis.

Fox JL, Hsu PH, Legator MS, Morrison LE, Seelig SA. Fox JL, et al. Among authors: seelig sa. Clin Chem. 1995 Nov;41(11):1554-9. Clin Chem. 1995. PMID: 7586542 Review.

10

Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action.

Yakes FM, Chinratanalab W, Ritter CA, King W, Seelig S, Arteaga CL. Yakes FM, et al. Cancer Res. 2002 Jul 15;62(14):4132-41. Cancer Res. 2002. PMID: 12124352

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters